Page 3 - Indian (NIFTY) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 10, 2026

Discover Indian Pharmaceuticals & Biotech Growth Stocks that are on the NIFTY. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

224 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
524742	₹1,708.70	9.0%	-8.6%	₹129.9b	₹2,500.00	21.2	11.8%	0.4%
500660	₹2,393.25	3.6%	-12.9%	₹405.4b	₹2,992.00	39.7	10.9%	1.8%
500488	₹25,770.05	-1.9%	-12.9%	₹547.6b	₹34,315.00	35.9	10.6%	1.8%
PFIZER	₹4,868.60	-0.4%	19.3%	₹222.7b	₹6,658.33	26.1	9.4%	0.7%
CIPLA	₹1,229.50	3.1%	-16.0%	₹993.2b	₹1,427.58	21.8	8.2%	1.1%
BLUEJET	₹406.85	13.9%	-40.5%	₹70.6b	₹499.17	24.0	7.5%	0.3%
ALKEM	₹5,440.00	3.5%	11.3%	₹650.4b	₹5,930.33	27.4	3.8%	0.8%
500124	₹1,232.00	1.2%	11.1%	₹1.0t	₹1,316.74	18.1	1.2%	0.6%
500257	₹2,332.70	2.5%	18.5%	₹1.1t	₹2,426.35	23.0	-1.2%	0.5%
ZYDUSLIFE	₹915.40	5.9%	5.4%	₹921.1b	₹993.73	18.7	-2.7%	1.2%
NATCOPHARM	₹1,104.20	7.5%	42.4%	₹197.8b	₹987.36	12.7	-31.2%	0.5%
532637	₹30.56	5.2%	-60.0%	₹483.7m	n/a	0.4	n/a	0%
544312	₹22.00	11.2%	7.3%	₹191.7m	n/a	2.7	n/a	n/a
530163	₹238.10	25.8%	-29.8%	₹3.1b	n/a	2.4	n/a	n/a
524632	₹33.84	6.1%	81.7%	₹14.8b	n/a	50.8	n/a	0.03%
SOTAC	₹102.00	-5.6%	-14.1%	₹1.1b	n/a	13.2	n/a	0.1%
SATKARTAR	₹181.00	8.2%	32.9%	₹2.8b	n/a	29.0	n/a	0.4%
512600	₹70.30	-0.8%	-19.2%	₹3.0b	n/a	30.4	n/a	n/a
AMANTA	₹112.18	3.8%	n/a	₹3.9b	n/a	28.2	n/a	n/a
524394	₹463.30	13.2%	0.9%	₹20.7b	n/a	27.7	n/a	0.2%
526075	₹39.87	6.0%	n/a	₹240.3m	n/a	44.4	n/a	n/a
AHCL	₹129.93	14.8%	n/a	₹6.9b	n/a	19.9	n/a	n/a
506197	₹258.65	10.4%	117.3%	₹27.4b	n/a	25.1	n/a	0.4%
530233	₹263.30	1.1%	7.4%	₹1.6b	n/a	50.7	n/a	n/a

Page 3 of 10